NCT00728221View on ClinicalTrials.gov

Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
HypertensionBlood PressureEndothelial Function
Interventions
DIETARY_SUPPLEMENT

Korean Red Ginseng

"Cultivated KRG-B (central body Korean Red Ginseng) obtained from Kyonggi-do Farm, Kyonggi-do Province, Korea.~Dosage form: whole root in capsules (3g)"

DIETARY_SUPPLEMENT

Korean Red Ginseng (Panax ginseng)

"Cultivated KRG-B (central body Korean Red Ginseng) obtained from Kyonggi-do Farm, Kyonggi-do Province, Korea.~Dosage form: total ginsenoside fraction in capsules"

DIETARY_SUPPLEMENT

Cornstarch

Placebo

DIETARY_SUPPLEMENT

Korean Red Ginseng (Panax Ginseng)

"Cultivated KRG-B (central body Korean Red Ginseng) obtained from Kyonggi-do Farm, Kyonggi-do Province, Korea.~Dosage form: total polysaccharide fraction (panaxans) in capsules"

Trial Locations (1)

M5C 1N8

St. Michael's Hospital Clinical Nutrition and Risk Factor Modification Centre, Toronto

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Canada

OTHER

lead

Unity Health Toronto

OTHER

NCT00728221 - Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation | Biotech Hunter | Biotech Hunter